Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sounds of nature may soothe fibromyalgia pain, study finds

NCT ID NCT07037134

Symptom relief Sponsor: Universidad de Granada Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether different types of sounds—like birdsong, traffic noise, or white noise—can reduce pain in people with fibromyalgia, a condition causing widespread pain. 88 adults with fibromyalgia listened to four different sound environments for 20 minutes each, one week apart. Researchers measured pain levels before and after each session to see if any sounds provided relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

88 people

The number who actually took part.

Started

Aug 2025

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * A diagnosis of fibromyalgia syndrome, documented in the medical record provided by the participant prior to enrollment. * Moderate or greater pain intensity during the preceding week, defined as a score higher than 3 on an 11-point Numeric Rating Scale. * Normal hearing confirmed by a hearing test, defined as a mean threshold of ≤ 20 dB HL at 0.125, 0.25, 0.5, 1, 2, 4, 6, and 8 kHz. * Ability to communicate in Spanish. * Provision of signed written informed consent to participate in the research. Exclusion Criteria: * A diagnosis of misophonia or auditory processing disorders, as documented in the participant's medical record. * Concurrent neuropathic or acute pain. * Severe cognitive impairment, defined as a Mini-Mental State Examination score ≤ 17. * Severe psychiatric disorders in the symptomatic phase. * History of substance abuse in the past 12 months or current substance use disorder as reported by the participant. * Changes in ongoing therapy during or within one month prior to study enrollment per participant self-reports. * Central nervous system disorders. * Any other serious or unstable medical condition that could interfere with study participation. * Known allergies or hypersensitivity to study materials. * Pregnancy, lactation, or being within three months postpartum at the time of study enrollment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fibromyalgia syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Pain fibromyalgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fibromyalgia syndrome

Contacts and locations

Locations

  • Faculty of Health Sciences, University of Granada

    Granada, Granada, 18016, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.